|
|
|
|
|
1.
|
Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines
CA Wilson, J Dering, G Bernardo, HM Rong, C Ginther, R Ferdman, AM Cook, R Finn, DJ Slamon Breast Cancer Research 2005, 7(Suppl 2):P4.25 (17 June 2005)
Full text | PDF
|
|
|
2.
|
Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells
Xinqun Li, Yang Lu, Ke Liang, Bolin Liu, Zhen Fan Breast Cancer Research 2005, 7:R589-R597 (24 May 2005)
Abstract | Full text | PDF | PubMed
|
|
|
3.
|
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer
Azita Monazzam, Raymond Josephsson, Carl Blomqvist, Jörgen Carlsson, Bengt Långström, Mats Bergström Breast Cancer Research 2007, 9:R45 (22 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
4.
|
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer
Aparna Mitra, Rebecca A Fillmore, Brandon J Metge, Mathur Rajesh, Yaguang Xi, Judy King, Jingfang Ju, Lewis Pannell, Lalita A Shevde, Rajeev S Samant Breast Cancer Research 2008, 10:R22 (7 March 2008)
Abstract | Full text | PDF | PubMed
|
|
|
5.
|
Immunohistochemical characterization of subtypes of male breast carcinoma
Yimin Ge, Nour Sneige, Mahmoud A Eltorky, Zhiqin Wang, E Lin, Yun Gong, Ming Guo Breast Cancer Research 2009, 11:R28 (14 May 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Luminal A and B subtypes are the main subtypes in male breast cancer, but have different immunophenotypical features compared to their female counterparts.
|
|
|
6.
|
Role of large volume 'mammotome' biopsy in the management of screen-detected radial scars
S Rajan, K Mankad, A-M Wason, P Carder Breast Cancer Research 2009, 11(Suppl 2):P9 (26 October 2009)
Full text | PDF
|
|
|
7.
|
MYB suppresses differentiation and apoptosis of human breast cancer cells
Yvette Drabsch, Robert G Ramsay, Thomas J Gonda Breast Cancer Research 2010, 12:R55 (26 July 2010)
Abstract | Full text | PDF | PubMed
|
|
|
8.
|
α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response
Tobias Hahn, Bhumasamudram Jagadish, Eugene A Mash, Kendra Garrison, Emmanuel T Akporiaye Breast Cancer Research 2011, 13:R4 (13 January 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
9.
|
Stratifying triple-negative breast cancer: which definition(s) to use?
Barbara Adamo, Carey K Anders Breast Cancer Research 2011, 13:105 (1 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
10.
|
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action
Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman, John Winslow Breast Cancer Research 2011, 13:R44 (15 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
11.
|
Luminal-B breast cancer and novel therapeutic targets
Ben Tran, Philippe L Bedard Breast Cancer Research 2011, 13:221 (30 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
12.
|
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E Place, Sung Jin Huh, Kornelia Polyak Breast Cancer Research 2011, 13:227 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
13.
|
Epigenetics in breast cancer: what's new?
Yi Huang, Shweta Nayak, Rachel Jankowitz, Nancy E Davidson, Steffi Oesterreich Breast Cancer Research 2011, 13:225 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
14.
|
Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice
Eun Kim, Mi-Ran Choi, Heesook Park, Minhee Kim, Ji Hong, Jae-Yong Lee, Hyang Chun, Ki Lee, Jung Yoon Park Breast Cancer Research 2011, 13:R78 (11 August 2011)
Abstract | Full text | PDF | PubMed
|
|
|
15.
|
Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Binoj C Nair, Sreeram Vallabhaneni, Rajeshwar R Tekmal, Ratna K Vadlamudi Breast Cancer Research 2011, 13:R80 (11 August 2011)
Abstract | Full text | PDF | PubMed
|
|
|
16.
|
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave, Vivek Mittal, Nicholas M Tan, Jenny C Chang Breast Cancer Research 2011, 14:202 (19 January 2012)
Abstract | Full text | PDF
|
|
|
17.
|
Molecular heterogeneity of luminal breast cancer
S Loi Breast Cancer Research 2011, 13(Suppl 2):O13 (16 November 2011)
Full text | PDF
|
|
|
18.
|
Balancing harms and benefits of service mammography screening programs: a cohort study.
Donella Puliti, Guido Miccinesi, Marco Zappa, Gianfranco Manneschi, Emanuele Crocetti, Eugenio Paci Breast Cancer Research 2012, 14:R9 (9 January 2012)
Abstract | Provisional PDF
| PubMed | F1000 Medicine
|
|
|
19.
|
Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study
Gitte V Sorensen, Deirdre P Cronin-Fenton, Henrik T Sorensen, Sinna P Ulrichsen, Lars Pedersen, Timothy L Lash Breast Cancer Research 2012, 14:R21 (3 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
20.
|
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumour-initiating cells
Kaiji Hu, Jennifer Law, Abbas Fotovati, Sandra E Dunn Breast Cancer Research 2012, 14:R22 (6 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
21.
|
Germline DNA copy number variation in familial and early-onset breast cancer
Ana C V Krepischi, Maria Isabel W Achatz, Erika M M Santos, Silvia S Costa, Bianca C G Lisboa, Helena Brentani, Tiago M Santos, Amanda Goncalves, Amanda F Nobrega, Peter L Pearson, Angela M Vianna-Morgante, Dirce M Carraro, Ricardo R Brentani, Carla Rosenberg Breast Cancer Research 2012, 14:R24 (7 February 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
22.
|
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean-Yves Pierga Breast Cancer Research 2012, 14:R29 (13 February 2012)
Abstract | Provisional PDF
|
Editor’s summary
Circulating tumor cell count shows no clear superiority over serum markers for predicting progression-free survival in metastatic breast cancer.
|
|
|
23.
|
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
Ida Johansson, Cecilia Nilsson, Pontus Berglund, Martin Lauss, Markus Ringner, Hakan Olsson, Lena Luts, Edith Sim, Sten Thorstensson, Marie-Louise Fjallskog, Ingrid Hedenfalk Breast Cancer Research 2012, 14:R31 (14 February 2012)
Abstract | Provisional PDF
|
|
|
24.
|
Premenopausal serum androgens and breast cancer risk: A nested case-control study
Anne Zeleniuch-Jacquotte, Yelena Afanasyeva, Rudolf Kaaks, Sabina Rinaldi, Stephanie Scarmo, Mengling Liu, Alan A Arslan, Paolo Toniolo, Roy E Shore, Karen L Koenig Breast Cancer Research 2012, 14:R32 (16 February 2012)
Abstract | Provisional PDF
|
Editor’s summary
A positive association between circulating testosterone and breast cancer risk was found in a case control study of American women, and the impact of including this in risk prediction models should be assessed.
|
|
|
25.
|
Breast cancer cell lines: friend or foe?
Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs Breast Cancer Res 2003, 5:89-95 (3 February 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|